Q9BUM1 (G6PC3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 99.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Glucose-6-phosphatase 3 Short name=G-6-Pase 3 Short name=G6Pase 3 EC=3.1.3.9 Alternative name(s): Glucose-6-phosphatase beta Short name=G6Pase-beta Ubiquitous glucose-6-phosphatase catalytic subunit-related protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 346 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Hydrolyzes glucose-6-phosphate to glucose in the endoplasmic reticulum. May form with the glucose-6-phosphate transporter (SLC37A4/G6PT) a ubiquitously expressed complex responsible for glucose production through glycogenolysis and gluconeogenesis. Probably required for normal neutrophil function. Ref.3 Ref.4 Ref.5 |
| Catalytic activity | D-glucose 6-phosphate + H2O = D-glucose + phosphate. Ref.4 |
| Enzyme regulation | Inhibited by vanadate. Ref.5 |
| Pathway | |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein Ref.5. |
| Tissue specificity | Ubiquitously expressed. Highly expressed in skeletal muscle, at intermediate levels in heart, brain, placenta, kidney, colon, thymus, spleen and pancreas. Also detected in testis, prostate, ovary, liver, lung, small intestine and peripheral blood lymphocytes. Ref.3 Ref.4 Ref.7 |
| Involvement in disease | Neutropenia severe congenital autosomal recessive 4 (SCN4) [MIM:612541]: A disorder of hematopoiesis characterized by maturation arrest of granulopoiesis at the level of promyelocytes with peripheral blood absolute neutrophil counts below 0.5 x 10(9)/l and early onset of severe bacterial infections. Dursun syndrome (DURSS) [MIM:612541]: A disease characterized by pulmonary arterial hypertension, cardiac abnormalities including secundum-type atrial septal defect, intermittent neutropenia, lymphopenia, monocytosis and anemia. |
| Sequence similarities | Belongs to the glucose-6-phosphatase family. |
| Caution | According to Ref.3, it has no hydrolytic activity. |
| Biophysicochemical properties | Kinetic parameters: 8 times less active compared to G6PC under the same experimental conditions. KM=1.0 mM for glucose-6-phosphate (at pH 5.5) Ref.4 Ref.5 KM=2.0 mM for glucose-6-phosphate (at pH 6.5) |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 346 | 346 | Glucose-6-phosphatase 3 | PRO_0000334512 | |||||
Regions | |||||||||
| Topological domain | 1 – 24 | 24 | Lumenal Potential | ||||||
| Transmembrane | 25 – 45 | 21 | Helical; Potential | ||||||
| Topological domain | 46 – 54 | 9 | Cytoplasmic Potential | ||||||
| Transmembrane | 55 – 75 | 21 | Helical; Potential | ||||||
| Topological domain | 76 – 114 | 39 | Lumenal Potential | ||||||
| Transmembrane | 115 – 135 | 21 | Helical; Potential | ||||||
| Topological domain | 136 – 146 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 147 – 164 | 18 | Helical; Potential | ||||||
| Topological domain | 165 – 169 | 5 | Lumenal Potential | ||||||
| Transmembrane | 170 – 186 | 17 | Helical; Potential | ||||||
| Topological domain | 187 – 197 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 198 – 218 | 21 | Helical; Potential | ||||||
| Topological domain | 219 – 254 | 36 | Lumenal Potential | ||||||
| Transmembrane | 255 – 273 | 19 | Helical; Potential | ||||||
| Topological domain | 274 – 283 | 10 | Cytoplasmic Potential | ||||||
| Transmembrane | 284 – 304 | 21 | Helical; Potential | ||||||
| Topological domain | 305 – 307 | 3 | Lumenal Potential | ||||||
| Transmembrane | 308 – 328 | 21 | Helical; Potential | ||||||
| Topological domain | 329 – 346 | 18 | Cytoplasmic Potential | ||||||
Sites | |||||||||
| Active site | 114 | 1 | Proton donor Potential | ||||||
| Active site | 167 | 1 | Nucleophile Ref.6 | ||||||
| Binding site | 79 | 1 | Substrate Potential | ||||||
| Binding site | 161 | 1 | Substrate Potential | ||||||
Natural variations | |||||||||
| Natural variant | 116 | 1 | M → K in SCN4; the patient also carries mutation Thr-166 in ELANE. Ref.11 | VAR_064508 | |||||
| Natural variant | 116 | 1 | M → V in DURSS. Ref.9 | VAR_064509 | |||||
| Natural variant | 185 | 1 | L → P in SCN4. Ref.8 | VAR_055156 | |||||
| Natural variant | 189 | 1 | R → Q in SCN4. Ref.11 | VAR_064510 | |||||
| Natural variant | 216 | 1 | T → I. Corresponds to variant rs34406052 [ dbSNP | Ensembl ]. | VAR_043378 | |||||
| Natural variant | 253 | 1 | R → H in SCN4; the mutant protein has no phosphatase activity in vitro; electron microscopic studies show enlarged rough endoplasmic reticulum consistent with increased stress. Ref.8 | VAR_055157 | |||||
| Natural variant | 260 | 1 | G → R in SCN4; loss of function. Ref.10 Ref.11 | VAR_064511 | |||||
| Natural variant | 262 | 1 | G → R in SCN4. Ref.8 | VAR_055158 | |||||
Experimental info | |||||||||
| Mutagenesis | 79 | 1 | R → A: Loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 114 | 1 | H → A: Loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 167 | 1 | H → A: Loss of catalytic activity. Ref.5 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Eye and Skin. |
| [3] | "Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein." Martin C.C., Oeser J.K., Svitek C.A., Hunter S.I., Hutton J.C., O'Brien R.M. J. Mol. Endocrinol. 29:205-222(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY. |
| [4] | "Identification and characterisation of a new human glucose-6-phosphatase isoform." Guionie O., Clottes E., Stafford K., Burchell A. FEBS Lett. 551:159-164(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY. |
| [5] | "A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia." Shieh J.-J., Pan C.-J., Mansfield B.C., Chou J.Y. J. Biol. Chem. 278:47098-47103(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, SUBCELLULAR LOCATION, MUTAGENESIS OF ARG-79; HIS-114 AND HIS-167. |
| [6] | "Histidine 167 is the phosphate acceptor in glucose-6-phosphatase-beta forming a phosphohistidine enzyme intermediate during catalysis." Ghosh A., Shieh J.-J., Pan C.-J., Chou J.Y. J. Biol. Chem. 279:12479-12483(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TOPOLOGY, ACTIVE SITE. |
| [7] | "Identification and characterization of a cDNA and the gene encoding the mouse ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein." Boustead J.N., Martin C.C., Oeser J.K., Svitek C.A., Hunter S.I., Hutton J.C., O'Brien R.M. J. Mol. Endocrinol. 32:33-53(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [8] | "A syndrome with congenital neutropenia and mutations in G6PC3." Boztug K., Appaswamy G., Ashikov A., Schaeffer A.A., Salzer U., Diestelhorst J., Germeshausen M., Brandes G., Lee-Gossler J., Noyan F., Gatzke A.-K., Minkov M., Greil J., Kratz C., Petropoulou T., Pellier I., Bellanne-Chantelot C., Rezaei N. Klein C.N. Engl. J. Med. 360:32-43(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS SCN4 PRO-185; HIS-253 AND ARG-262, CHARACTERIZATION OF VARIANT SCN4 HIS-253. |
| [9] | "Mutations in the G6PC3 gene cause Dursun syndrome." Banka S., Newman W.G., Ozgul R.K., Dursun A. Am. J. Med. Genet. A 152:2609-2611(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DURSS VAL-116. |
| [10] | "Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis." McDermott D.H., De Ravin S.S., Jun H.S., Liu Q., Priel D.A., Noel P., Takemoto C.M., Ojode T., Paul S.M., Dunsmore K.P., Hilligoss D., Marquesen M., Ulrick J., Kuhns D.B., Chou J.Y., Malech H.L., Murphy P.M. Blood 116:2793-2802(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT SCN4 ARG-260, CHARACTERIZATION OF VARIANT SCN4 ARG-260. |
| [11] | "Digenic mutations in severe congenital neutropenia." Germeshausen M., Zeidler C., Stuhrmann M., Lanciotti M., Ballmaier M., Welte K. Haematologica 95:1207-1210(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS SCN4 LYS-116; GLN-189 AND ARG-260. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | CH471178 Genomic DNA. Translation: EAW51638.1. BC002494 mRNA. Translation: AAH02494.2. BC021574 mRNA. Translation: AAH21574.1. |
| IPI | IPI00031052. |
| RefSeq | NP_612396.1. NM_138387.3. |
| UniGene | Hs.294005. |
3D structure databases | |
| ProteinModelPortal | Q9BUM1. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000269097. |
PTM databases | |
| PhosphoSite | Q9BUM1. |
Polymorphism databases | |
| DMDM | 74733234. |
Proteomic databases | |
| PaxDb | Q9BUM1. |
| PeptideAtlas | Q9BUM1. |
| PRIDE | Q9BUM1. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000269097; ENSP00000269097; ENSG00000141349. |
| GeneID | 92579. |
| KEGG | hsa:92579. |
| UCSC | uc002iex.3. human. |
Organism-specific databases | |
| CTD | 92579. |
| GeneCards | GC17P042148. |
| H-InvDB | HIX0013874. |
| HGNC | HGNC:24861. G6PC3. |
| MIM | 611045. gene. 612541. phenotype. |
| neXtProt | NX_Q9BUM1. |
| Orphanet | 486. Autosomal dominant severe congenital neutropenia. 178503. Dursun syndrome. |
| PharmGKB | PA134968446. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG82628. |
| HOGENOM | HOG000264239. |
| HOVERGEN | HBG003560. |
| InParanoid | Q9BUM1. |
| OMA | LWVTFLG. |
| OrthoDB | EOG441QCC. |
| PhylomeDB | Q9BUM1. |
Enzyme and pathway databases | |
| Reactome | REACT_111217. Metabolism. REACT_15518. Transmembrane transport of small molecules. |
| SABIO-RK | Q9BUM1. |
| UniPathway | UPA00138. |
Gene expression databases | |
| Bgee | Q9BUM1. |
| CleanEx | HS_G6PC3. |
| Genevestigator | Q9BUM1. |
Family and domain databases | |
| Gene3D | 1.20.144.10. 1 hit. |
| InterPro | IPR016275. Glucose-6-phosphatase. IPR016118. P_Acid_Pase/Cl_peroxidase_N. IPR000326. P_Acid_Pase_2/haloperoxidase. [Graphical view] |
| Pfam | PF01569. PAP2. 1 hit. [Graphical view] |
| PIRSF | PIRSF000905. Glucose-6-phosphatase. 1 hit. |
| SMART | SM00014. acidPPc. 1 hit. [Graphical view] |
| SUPFAM | SSF48317. AcPase_VanPerase. 1 hit. |
| ProtoNet | Search... |
Other | |
| ChiTaRS | G6PC3. human. |
| GenomeRNAi | 92579. |
| NextBio | 77803. |
| SOURCE | Search... |
Entry information
| Entry name | G6PC3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9BUM1 Secondary accession number(s): Q8WU15 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
